FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2011363588> ?p ?o ?g. }

• W2011363588 endingPage "e115" @default.
• W2011363588 startingPage "e105" @default.
• W2011363588 abstract "BackgroundProgress in tuberculosis control worldwide, including achievement of 2015 global targets, requires adequate financing sustained for many years. WHO began yearly monitoring of tuberculosis funding in 2002. We used data reported to WHO to analyse tuberculosis funding from governments and international donors (in real terms, constant 2011 US$) and associated progress in tuberculosis control in low-income and middle-income countries between 2002 and 2011. We then assessed funding needed to 2015 and how this funding could be mobilised.MethodsWe included low-income and middle-income countries that reported data about financing for tuberculosis to WHO and had at least three observations between 2002 and 2011. When data were missing for specific country–year combinations, we imputed the missing data. We aggregated country-specific results for eight country groups defined according to income level, political and economic profile, geography, and tuberculosis burden. We compared absolute changes in total funding with those in the total number of patients successfully treated and did cross-country comparisons of cost per successfully treated patient relative to gross domestic product. We estimated funding needs for tuberculosis care and control for all low-income and middle-income countries to 2015, and compared these needs with domestic funding that could be mobilised.FindingsTotal funding grew from $1·7 billion in 2002 to $4·4 billion in 2011. It was mostly spent on diagnosis and treatment of drug-susceptible tuberculosis. 43 million patients were successfully treated, usually for $100–500 per person in countries with high burdens of tuberculosis. Domestic funding rose from $1·5 billion to $3·9 billion per year, mostly in Brazil, Russia, India, China, and South Africa (BRICS), which collectively account for 45% of global cases, where national contributions accounted for more than 95% of yearly funding. Donor funding increased from $0·2 billion in 2002 to $0·5 billion in 2011, and accounted for a mean of 39% of funding in the 17 countries with the highest burdens (excluding BRICS) and a mean of 67% in low-income countries by 2011. BRICS and upper middle-income countries could mobilise almost all of their funding needs to 2015 from domestic sources. A full response to the tuberculosis epidemic to 2015, including investments to tackle multidrug-resistant tuberculosis, will require international donor funding of $1·6–2·3 billion each year.InterpretationFunding for tuberculosis control increased substantially between 2002 and 2011, resulting in impressive and cost-effective gains. The increasing self-sufficiency of many countries, including BRICS, which account for almost half the world's tuberculosis cases, is a success story for control of tuberculosis. Nonetheless, international donor funding remains crucial in many countries and more is needed to achieve 2015 targets.FundingNone. Progress in tuberculosis control worldwide, including achievement of 2015 global targets, requires adequate financing sustained for many years. WHO began yearly monitoring of tuberculosis funding in 2002. We used data reported to WHO to analyse tuberculosis funding from governments and international donors (in real terms, constant 2011 US$) and associated progress in tuberculosis control in low-income and middle-income countries between 2002 and 2011. We then assessed funding needed to 2015 and how this funding could be mobilised. We included low-income and middle-income countries that reported data about financing for tuberculosis to WHO and had at least three observations between 2002 and 2011. When data were missing for specific country–year combinations, we imputed the missing data. We aggregated country-specific results for eight country groups defined according to income level, political and economic profile, geography, and tuberculosis burden. We compared absolute changes in total funding with those in the total number of patients successfully treated and did cross-country comparisons of cost per successfully treated patient relative to gross domestic product. We estimated funding needs for tuberculosis care and control for all low-income and middle-income countries to 2015, and compared these needs with domestic funding that could be mobilised. Total funding grew from $1·7 billion in 2002 to $4·4 billion in 2011. It was mostly spent on diagnosis and treatment of drug-susceptible tuberculosis. 43 million patients were successfully treated, usually for $100–500 per person in countries with high burdens of tuberculosis. Domestic funding rose from $1·5 billion to $3·9 billion per year, mostly in Brazil, Russia, India, China, and South Africa (BRICS), which collectively account for 45% of global cases, where national contributions accounted for more than 95% of yearly funding. Donor funding increased from $0·2 billion in 2002 to $0·5 billion in 2011, and accounted for a mean of 39% of funding in the 17 countries with the highest burdens (excluding BRICS) and a mean of 67% in low-income countries by 2011. BRICS and upper middle-income countries could mobilise almost all of their funding needs to 2015 from domestic sources. A full response to the tuberculosis epidemic to 2015, including investments to tackle multidrug-resistant tuberculosis, will require international donor funding of $1·6–2·3 billion each year. Funding for tuberculosis control increased substantially between 2002 and 2011, resulting in impressive and cost-effective gains. The increasing self-sufficiency of many countries, including BRICS, which account for almost half the world's tuberculosis cases, is a success story for control of tuberculosis. Nonetheless, international donor funding remains crucial in many countries and more is needed to achieve 2015 targets." @default.
• W2011363588 created "2016-06-24" @default.
• W2011363588 creator A5015462710 @default.
• W2011363588 creator A5016454522 @default.
• W2011363588 creator A5081242987 @default.
• W2011363588 creator A5082203779 @default.
• W2011363588 date "2013-08-01" @default.
• W2011363588 modified "2023-10-16" @default.
• W2011363588 title "Domestic and donor financing for tuberculosis care and control in low-income and middle-income countries: an analysis of trends, 2002–11, and requirements to meet 2015 targets" @default.
• W2011363588 cites W1975018794 @default.
• W2011363588 cites W1996763863 @default.
• W2011363588 cites W2019744795 @default.
• W2011363588 cites W2032003852 @default.
• W2011363588 cites W2046620897 @default.
• W2011363588 cites W2059552603 @default.
• W2011363588 cites W2065762354 @default.
• W2011363588 cites W2098979740 @default.
• W2011363588 cites W2138041013 @default.
• W2011363588 cites W2145239419 @default.
• W2011363588 cites W2147335020 @default.
• W2011363588 cites W2171001078 @default.
• W2011363588 doi "https://doi.org/10.1016/s2214-109x(13)70032-9" @default.
• W2011363588 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/25104145" @default.
• W2011363588 hasPublicationYear "2013" @default.
• W2011363588 type Work @default.
• W2011363588 sameAs 2011363588 @default.
• W2011363588 citedByCount "41" @default.
• W2011363588 countsByYear W20113635882013 @default.
• W2011363588 countsByYear W20113635882014 @default.
• W2011363588 countsByYear W20113635882015 @default.
• W2011363588 countsByYear W20113635882016 @default.
• W2011363588 countsByYear W20113635882017 @default.
• W2011363588 countsByYear W20113635882018 @default.
• W2011363588 countsByYear W20113635882019 @default.
• W2011363588 countsByYear W20113635882020 @default.
• W2011363588 countsByYear W20113635882021 @default.
• W2011363588 countsByYear W20113635882022 @default.
• W2011363588 countsByYear W20113635882023 @default.
• W2011363588 crossrefType "journal-article" @default.
• W2011363588 hasAuthorship W2011363588A5015462710 @default.
• W2011363588 hasAuthorship W2011363588A5016454522 @default.
• W2011363588 hasAuthorship W2011363588A5081242987 @default.
• W2011363588 hasAuthorship W2011363588A5082203779 @default.
• W2011363588 hasBestOaLocation W20113635881 @default.
• W2011363588 hasConcept C114350782 @default.
• W2011363588 hasConcept C142724271 @default.
• W2011363588 hasConcept C144133560 @default.
• W2011363588 hasConcept C162324750 @default.
• W2011363588 hasConcept C2781069245 @default.
• W2011363588 hasConcept C2993767641 @default.
• W2011363588 hasConcept C50522688 @default.
• W2011363588 hasConcept C71924100 @default.
• W2011363588 hasConcept C83864248 @default.
• W2011363588 hasConceptScore W2011363588C114350782 @default.
• W2011363588 hasConceptScore W2011363588C142724271 @default.
• W2011363588 hasConceptScore W2011363588C144133560 @default.
• W2011363588 hasConceptScore W2011363588C162324750 @default.
• W2011363588 hasConceptScore W2011363588C2781069245 @default.
• W2011363588 hasConceptScore W2011363588C2993767641 @default.
• W2011363588 hasConceptScore W2011363588C50522688 @default.
• W2011363588 hasConceptScore W2011363588C71924100 @default.
• W2011363588 hasConceptScore W2011363588C83864248 @default.
• W2011363588 hasIssue "2" @default.
• W2011363588 hasLocation W20113635881 @default.
• W2011363588 hasLocation W20113635882 @default.
• W2011363588 hasLocation W20113635883 @default.
• W2011363588 hasLocation W20113635884 @default.
• W2011363588 hasOpenAccess W2011363588 @default.
• W2011363588 hasPrimaryLocation W20113635881 @default.
• W2011363588 hasRelatedWork W1916580408 @default.
• W2011363588 hasRelatedWork W2206558901 @default.
• W2011363588 hasRelatedWork W2342011470 @default.
• W2011363588 hasRelatedWork W2412495567 @default.
• W2011363588 hasRelatedWork W2412999881 @default.
• W2011363588 hasRelatedWork W2415759662 @default.
• W2011363588 hasRelatedWork W2437662169 @default.
• W2011363588 hasRelatedWork W2884171184 @default.
• W2011363588 hasRelatedWork W3215265998 @default.
• W2011363588 hasRelatedWork W4236212584 @default.
• W2011363588 hasVolume "1" @default.
• W2011363588 isParatext "false" @default.
• W2011363588 isRetracted "false" @default.
• W2011363588 magId "2011363588" @default.
• W2011363588 workType "article" @default.